Cardiomo

by Cardiomo, Inc.  · Based in United States → — A medical-grade wearable device that monitors vital signs and uses an AI engine to detect cardiovascular diseases and provide life-saving alerts.
Cardiology Geriatrics Internal Medicine
Website
Claim this tool
Is this the maker? Claim the company →

Contact for pricing

Overview

Cardiomo is an innovative medtech company that offers a wearable continuous remote monitoring solution with an AI engine to deliver real-time, actionable insights for early detection of arrhythmias and other cardiovascular diseases. The Cardiomo device is a waterproof wearable patch with biosensors that continuously tracks vital signs such as ECG, heart rate, respiratory rate, and skin temperature. The data is transmitted via Bluetooth to a mobile application (available for Android and iOS) and then seamlessly sent to a HIPAA-compliant cloud for analysis by proprietary AI algorithms. This system is designed to detect abnormalities, provide personalized health assessments, and send instant notifications to patients, relatives, and caregivers in case of critical deviations or emergencies like falls or heart attacks.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Medical-grade wearable patch
  • Continuous vital sign monitoring (ECG, heart rate, respiration, skin temperature)
  • AI-powered disease detection (arrhythmias, cardiovascular events)
  • Real-time alerts and notifications
  • Mobile application (Android and iOS)
  • HIPAA-compliant cloud analytics
  • Fall detection
  • Long battery life (up to 7-10 days)
  • Waterproof design
  • Data dashboard for clinicians and caregivers

Use Cases

  • Remote monitoring of patients with cardiovascular conditions
  • Early detection of heart attacks and strokes
  • Preventive care for at-risk individuals and the elderly
  • Continuous health monitoring for individuals and families
  • Supporting health coaches and corporate wellness programs
  • Monitoring employees in dangerous conditions

What Physicians Need to Know

ECG/EKG Analysis Capability
Cardiomo offers continuous, real-time ECG/EKG monitoring. Its wearable patch with biosensors tracks vital signs including ECG, heart rate variability, respiratory rate, and skin temperature. The data is analyzed by proprietary AI algorithms to detect cardiac events and abnormalities.
Arrhythmia Detection Accuracy
Cardiomo's proprietary AI algorithms are trained to detect arrhythmias and other cardiac events with a reported accuracy of 99.63%. Wearable devices, in general, have shown high diagnostic accuracy for detecting cardiac arrhythmias, with reported sensitivities up to 100% and specificities up to 95%.
Heart Failure Risk Prediction
Cardiomo's AI-based platform aims to predict imminent threats and provide early life-saving alerts, which can contribute to preventive care for heart diseases. While specific details on heart failure risk prediction models for Cardiomo are not extensively detailed, AI predictive modeling for CVD risk generally combines various data points to deliver actionable cardiovascular risk predictions.
Cardiac Monitoring Integration
Cardiomo is a wearable patch that provides continuous, 24/7 remote cardiac monitoring. It transmits data via Bluetooth to a mobile application (Android and iOS), which then sends the information to a secure, HIPAA-compliant cloud for analysis. The system is designed for long-term monitoring, with a battery life of up to 10 days and is waterproof.
Real-Time Alert Capability
Cardiomo provides instant notifications and alerts to patients, relatives, and care providers when unusual behavior or critical cardiac events are detected by its AI algorithms. The alerts can include emergency notifications for events like falls or heart attacks. Messages are color-coded to indicate the level of danger.
Physician Tip

Cardiomo offers continuous, real-time ECG and vital sign monitoring, providing event annotations for faster diagnosis and the potential to predict medically actionable events. This can be particularly useful for long-term remote patient monitoring, especially for individuals with cardiovascular diseases or those at high risk. The system's real-time alerts can help in timely interventions. Consider integrating Cardiomo for patients requiring ongoing cardiac oversight, leveraging its AI-driven insights for preventive care and early detection of cardiac events.

Cardiomo's data is channeled via a proprietary mobile app to a secure, HIPAA-compliant cloud for analysis. The company has also explored partnerships for integration into telecommunication networks for distribution. While specific integrations with broader EHR systems or other cardiology AI platforms are not detailed, the cloud-based system and mobile app suggest a foundation for potential API-based integrations. Cardiomo is listed as a medical-grade system trusted by clinicians.

Details

Category Cardiology AI, Wearables & Remote Monitoring (RPM)
Pricing Contact for pricing
  • Previously offered at $200 with a $10 monthly subscription, with early bird pricing at $100
  • Current pricing details are not publicly available
DeploymentCloud-based with wearable device and mobile app
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status Unknown AI-estimated

Cardiomo has plans to submit documents to the FDA for 510(k) clearance for the American market. They are also working towards obtaining CE Mark approval in Europe.
Integrations
EHR Not specified
Specialties Cardiology, Geriatrics, Internal Medicine

What the Web Says

Cardiomo is a non-invasive, wearable patch designed for continuous heart health monitoring, aiming to detect cardiovascular diseases like strokes and heart attacks early. It provides 24/7 monitoring of vital signs, including ECG, heart rate, respiration rate, skin temperature, body position, activity, and sleep quality. The device sends data to a cloud for AI-powered analysis and alerts users, relatives, and healthcare providers to potential issues. Cardiomo is positioned as a medical device, not a fitness tracker, and has undergone pilot projects in Ukraine, Austria, and Portugal, with FDA approval pending.

Overall: Mixed

Strengths

  • Continuous 24/7 heart monitoring and vital sign tracking (ECG, heart rate, respiration, skin temperature, body position, activity, sleep quality).
  • Aims to detect up to 40 diseases, including strokes and heart attacks, early.
  • Sends instant notifications and alerts to users, relatives, and caregivers/doctors in case of abnormalities.
  • Long battery life (7-10 days) compared to some competitors.
  • Waterproof, allowing for wear during showers and swimming.
  • Non-invasive and user-friendly design.

Limitations

  • Some reviewers noted a 'plasticky' feel, suggesting it might not feel as durable or high-quality as some competitors.
  • Charging is via USB cable, not wireless, which could be an inconvenience for some users.
  • One Reddit user questioned the value of 'medical grade' data for average fitness users, though acknowledged raw data export is good for those who know how to use it.
  • A review from 2017 mentioned a $10 monthly subscription fee after an initial purchase price.
  • FDA approval was pending as of December 2023.
  • Limited independent user reviews available on platforms like Reddit, G2, or Capterra specifically for Cardiomo (some results were for 'CardioMood' or 'CardioMems').

Based on reviews from: Reddit, Wareable, SPINOFF.COM, Cardiomo.com, YouTube

Last updated: 2026-07-02

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Cardiomo

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

Wareable
Cardiomo's AI-powered smart patch wants to keep tabs on your heart
Cardiomo developed a stick-on wearable that uses AI to detect heart problems, inspired by the CEO's mother's health concerns. The device monitors ECG, respiration, and skin temperature, and can alert users, relatives, and doctors to potential issues, aiming to recognize up to 40 diseases.
2017-03
SPINOFF.COM
Cardiomo remote health monitoring
Cardiomo offers 24/7 heart vital monitoring to detect potential strokes or heart attacks within two hours, with the goal of saving lives through early detection. The company is seeking FDA approval in the US and CE Mark approval in Europe.
2018-05
Infosoft
Cardiomo u2013 your digital cardiograph
Cardiomo provides a device, app, and software for real-time heart health monitoring, including ECG, heart rate, respiratory rate, and skin temperature. The waterproof device has a 7-day battery life and transmits data to a mobile app and cloud for analysis.
2023-08
Startup.Network
Cardiomo
Cardiomo is an innovative medtech company offering continuous remote monitoring with an AI engine for early detection of arrhythmias. Their waterproof wearable patch has a 10-day battery life and provides medical-grade data for preventive care and event prediction.
2024-11
DPH2026
Cardiomo -the solution in remote patient monitoring - DPH2026
Cardiomo was shortlisted for the DPH Innovation Prize 2019 for its wearable device that remotely monitors patient vitals and predicts critical cardiac events in real-time. The system aims to provide continuous, medical-grade cardiac monitoring with an AI engine for early alerts.
2026-06
BioSupply Trends Quarterly
Technological Advancements in Cardiology: Improved Monitoring
With a projected shortage of cardiologists, remote cardiac monitoring solutions are becoming crucial. The article highlights FDA-cleared products transforming cardiac care, emphasizing the need for innovative solutions to ensure timely and effective treatment.
2026-03
Healthline
Cardiovascular Disease: New AI Tool Spots Risks During Routine ECG
The FDA recently cleared EchoNext, an AI tool that detects hidden structural heart disease during routine ECGs, marking a significant advancement in early detection of cardiovascular disease. This tool analyzes ECG waveforms to identify high-risk individuals for further echocardiogram assessment.
2026-06
HCPLive
6 Cardiology Headlines You Missed in June 2026
June 2026 saw significant cardiology news, including FDA approvals for new therapies and updated guidelines for cardiovascular-kidney-metabolic syndrome. These developments underscore ongoing efforts to improve treatment and management of heart-related conditions.
2026-07

Videos

Product demos, reviews, and walkthroughs for Cardiomo.

View all on YouTube

Frequently Asked Questions

Cardiomo's AI utilizes machine learning algorithms trained on large datasets of ECGs to identify anomalies and potential cardiac events. While it can detect a wide range of arrhythmias and patterns, its role is to augment, not replace, a cardiologist's diagnosis. The system provides preliminary analysis and alerts, which still require physician review and confirmation for definitive diagnosis and treatment planning.
Cardiomo is designed with patient data privacy in mind, adhering to regulations like HIPAA and GDPR for data security and confidentiality. As a medical device, it undergoes rigorous testing and seeks necessary regulatory clearances, such as FDA approval, to ensure its safety and efficacy for clinical use. Physicians should verify the current regulatory status in their specific region.
Common alternatives to Cardiomo include traditional Holter monitors, mobile cardiac outpatient telemetry (MCOT) devices, and other wearable ECG monitors. The choice depends on the suspected condition, desired monitoring duration, and patient lifestyle. Cardiomo's continuous, passive monitoring may be preferred for long-term, asymptomatic screening, while MCOT might be chosen for higher-acuity, symptomatic events requiring immediate data transmission.
The pricing model for Cardiomo typically involves a subscription fee for the monitoring service and potentially a cost for the device itself. This can vary based on the specific features and duration of monitoring. Physicians should inquire about detailed pricing structures, including any potential for insurance reimbursement, and compare these costs against other remote monitoring solutions to assess overall value and patient affordability.
While Cardiomo's AI is robust, it has limitations. Its accuracy can be affected by signal quality, patient movement, and certain artifacts. It may also have reduced sensitivity for rare arrhythmias or in patients with complex cardiac histories, pacemakers, or other implanted devices. Physicians should be aware of these limitations and use Cardiomo as part of a comprehensive diagnostic approach.
Cardiomo aims to integrate with existing EHR systems to streamline data flow and physician workflow. This typically involves secure APIs that allow for the transfer of patient data and monitoring reports directly into the patient's chart. Physicians can then review the AI-generated insights and alerts within their familiar EHR interface, facilitating efficient decision-making and documentation.
Cardiomo typically offers comprehensive technical support and training programs for physicians and their staff. This includes onboarding sessions, user manuals, online resources, and dedicated customer support channels to address any technical issues or questions. The goal is to ensure that healthcare providers can effectively set up, operate, and interpret the data from the Cardiomo device and platform.

Compare Cardiomo

VS
AI-Rad Companion (Cardiovascular) vs Cardiomo
Cardiology AI Adjacent · 65/100
These tools are adjacent in their focus on cardiovascular health but serve different stages of care. AI-Rad Companion is an AI-powered image processing software for physicians to analyze…
VS
qXR-CTR vs Cardiomo
Cardiology AI Adjacent · 60/100
qXR-CTR and Cardiomo are adjacent tools in cardiology AI, addressing different aspects of heart health. qXR-CTR focuses on automated cardiothoracic ratio assessment from chest X-rays for heart size…
VS
HealthCCSng vs Cardiomo
Cardiology AI Adjacent · 60/100
HealthCCSng and Cardiomo both address cardiovascular health, but they do so with different approaches. HealthCCSng focuses on identifying coronary artery disease risk through AI analysis of CT scans,…
VS
Libby Echo:Prio vs Cardiomo
Cardiology AI Adjacent · 60/100
Libby Echo:Prio is an AI platform for analyzing existing echocardiogram images to provide decision support and automated measurements for clinicians. Cardiomo, on the other hand, is a medical-grade…

Related Tools

Cardiomatics
Cardiomatics
Cardiology AI
Cardiomatics is a cloud-based, AI-powered software for analyzing ambulatory (Holter) ECG tests, using clinically validated algorithms to provide accurate and high-quality results for cardiac diagnostics. It aims to streamline ECG analysis, reduce interpretation time, and improve diagnostic accuracy for various heart conditions.
Paid, credit-based or subscription
SafeBeat Rx App
SafeBeat Rx, Inc.
Cardiology AI
An AI application designed to support safe pharmacological treatment and monitoring for cardiac arrhythmias.
PreemptiveAI Clinical SDK
Measure Labs, Inc. (Dba Preemptiveai, Inc.)
Cardiology AI
A clinical software development kit using AI to model and predict cardiovascular health metrics, aiming to shift healthcare from reactive to proactive by providing early health risk signals.
Clarius Ejection Fraction AI
Clarius Mobile Health Corp.
Cardiology AI
Clarius Ejection Fraction AI is an AI-powered ultrasound tool for automated left ventricular ejection fraction calculation, integrated into the Clarius Ultrasound App for real-time cardiac assessments.
Contact for pricing
Automated Aortic Stenosis Software (AutoAS)
Multiple companies are developing Automated Aortic Stenosis Software (AutoAS) or similar AI-powered solutions. Notable ones include iCardio.ai, Us2.ai, AccurKardia, HeartSciences Inc., and Echo IQ.
Cardiology AI
Automated Aortic Stenosis Software (AutoAS) is an ultrasound application by GE Medical Systems that provides automated assessment of aortic stenosis to enhance diagnostic efficiency and consistency.
ECG-AI Pulmonary Hypertension (PH) 12-Lead algorithm
Anumana
Cardiology AI
An AI algorithm that analyzes standard 12-lead ECG recordings to detect signs of pulmonary hypertension, aiming for earlier diagnosis and improved patient outcomes.

See all Cardiology AI tools →

Suggest an Edit → | Last Verified: 2026-07-01 | First Added: 2026-07-01

Investors who backed Cardiomo

Funded through the company that built this tool.

Kamet Ventures
Startup Studio T3
Paris, France
unknown
Kamet Ventures is the venture builder and investor arm of AXA, the French global insurance group, with a thesis built around building…
AI/ML in Healthcare Care Delivery / Tech-Enabled Services
AI Tool Finder
AI-powered search. Results may not be comprehensive.